This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, A.
Right arrow Articles by Miller, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, A.
Right arrow Articles by Miller, G.

 Previous Article  |  Next Article 

Journal of Virology, June 1999, p. 4543-4551, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Amino Acid Substitutions Reveal Distinct Functions of Serine 186 of the ZEBRA Protein in Activation of Early Lytic Cycle Genes and Synergy with the Epstein-Barr Virus R Transactivator

Amy Francis,1,dagger Tobias Ragoczy,1 Lyn Gradoville,2 Lee Heston,2 Ayman El-Guindy,1 Yoshimi Endo,1 and George Miller1,2,*

Departments of Molecular Biophysics and Biochemistry1 and Pediatrics and Epidemiology & Public Health,2 Yale University School of Medicine, New Haven, Connecticut 06520

Received 16 October 1998/Accepted 18 February 1999

The ZEBRA protein mediates the switch between the latent and lytic life cycles of Epstein-Barr virus. Z(S186A), a point mutant in ZEBRA's basic domain in which serine 186 is changed to alanine, is unable to induce expression of lytic cycle mRNAs or proteins from the latent EBV genome even though it retains the ability to activate transcription from reporters bearing known ZEBRA-responsive promoters (A. L. Francis et al., J. Virol. 71:3054-3061, 1997). We now describe three distinct phenotypes of ZEBRA mutants bearing different amino acid substitutions at S186. These phenotypes are based on the capacity of the mutants to activate expression of the BRLF1 and BMRF1 genes, which are targets of ZEBRA's action, and to synergize with the BRLF1 gene product Rta (R transactivator) in activating expression of downstream genes. One mutant class, represented by Z(S186T), was similar to the wild type, although reduced in the capacity to activate BRLF1 and BMRF1 early lytic cycle genes from the latent virus. A second class, represented by Z(S186C) and Z(S186G), was impaired in transcriptional activation, unable to activate early lytic cycle products from the latent virus, and not rescued by overexpression of Rta. A third class, Z(S186A), although unable by itself to activate BRLF1 or other lytic cycle genes, synergized with Rta. Rta rescued the capacity of Z(S186A) to activate the BMRF1 early lytic cycle gene from the latent virus. All mutant classes bound to DNA in vitro, although their capacity to bind to different ZEBRA response elements varied. Serine 186 of ZEBRA is a critical residue that is required for the distinct activities of induction of BRLF1 expression and for synergy with Rta. Since only Z(S186T) among the mutants behaved similarly to the wild type, activation of BRLF1 likely requires phosphorylation of S186. However, since Z(S186A) could synergize with Rta, synergy with Rta does not appear to be dependent on phosphorylation of S186. S186 likely mediates DNA recognition on the BRLF1 promoter in the context of the latent virus, protein-protein interactions, or both. The Z(S186) mutants define the amino acid side chains required for these functions.


* Corresponding author. Mailing address: Department of Pediatrics, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520. Phone: (203) 785-4758. Fax: (203) 785-6961. E-mail: george_miller{at}qm.yale.edu.

dagger Present address: Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pa.


Journal of Virology, June 1999, p. 4543-4551, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Li, D., Qian, L., Chen, C., Shi, M., Yu, M., Hu, M., Song, L., Shen, B., Guo, N. (2009). Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation. J. Immunol. 182: 1799-1809 [Abstract] [Full Text]  
  • El-Guindy, A., Heston, L., Delecluse, H.-J., Miller, G. (2007). Phosphoacceptor Site S173 in the Regulatory Domain of Epstein-Barr Virus ZEBRA Protein Is Required for Lytic DNA Replication but Not for Activation of Viral Early Genes. J. Virol. 81: 3303-3316 [Abstract] [Full Text]  
  • Heston, L., El-Guindy, A., Countryman, J., Dela Cruz, C., Delecluse, H.-J., Miller, G. (2006). Amino Acids in the Basic Domain of Epstein-Barr Virus ZEBRA Protein Play Distinct Roles in DNA Binding, Activation of Early Lytic Gene Expression, and Promotion of Viral DNA Replication.. J. Virol. 80: 9115-9133 [Abstract] [Full Text]  
  • El-Guindy, A. S., Paek, S. Y., Countryman, J., Miller, G. (2006). Identification of Constitutive Phosphorylation Sites on the Epstein-Barr Virus ZEBRA Protein. J. Biol. Chem. 281: 3085-3095 [Abstract] [Full Text]  
  • Wang, P., Day, L., Dheekollu, J., Lieberman, P. M. (2005). A Redox-Sensitive Cysteine in Zta Is Required for Epstein-Barr Virus Lytic Cycle DNA Replication. J. Virol. 79: 13298-13309 [Abstract] [Full Text]  
  • Chang, M., Brown, H. J., Collado-Hidalgo, A., Arevalo, J. M., Galic, Z., Symensma, T. L., Tanaka, L., Deng, H., Zack, J. A., Sun, R., Cole, S. W. (2005). {beta}-Adrenoreceptors Reactivate Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication via PKA-Dependent Control of Viral RTA. J. Virol. 79: 13538-13547 [Abstract] [Full Text]  
  • Izumiya, Y., Ellison, T. J., Yeh, E. T. H., Jung, J. U., Luciw, P. A., Kung, H.-J. (2005). Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Represses Gene Transcription via SUMO Modification. J. Virol. 79: 9912-9925 [Abstract] [Full Text]  
  • Bhende, P. M., Seaman, W. T., Delecluse, H.-J., Kenney, S. C. (2005). BZLF1 Activation of the Methylated Form of the BRLF1 Immediate-Early Promoter Is Regulated by BZLF1 Residue 186. J. Virol. 79: 7338-7348 [Abstract] [Full Text]  
  • El-Guindy, A. S., Miller, G. (2004). Phosphorylation of Epstein-Barr Virus ZEBRA Protein at Its Casein Kinase 2 Sites Mediates Its Ability To Repress Activation of a Viral Lytic Cycle Late Gene by Rta. J. Virol. 78: 7634-7644 [Abstract] [Full Text]  
  • Pavlova, I. V., Virgin, H. W. IV, Speck, S. H. (2003). Disruption of Gammaherpesvirus 68 Gene 50 Demonstrates that Rta Is Essential for Virus Replication. J. Virol. 77: 5731-5739 [Abstract] [Full Text]  
  • Deng, Z., Chen, C.-J., Chamberlin, M., Lu, F., Blobel, G. A., Speicher, D., Cirillo, L. A., Zaret, K. S., Lieberman, P. M. (2003). The CBP Bromodomain and Nucleosome Targeting Are Required for Zta-Directed Nucleosome Acetylation and Transcription Activation. Mol. Cell. Biol. 23: 2633-2644 [Abstract] [Full Text]  
  • El-Guindy, A. S., Heston, L., Endo, Y., Cho, M.-S., Miller, G. (2002). Disruption of Epstein-Barr Virus Latency in the Absence of Phosphorylation of ZEBRA by Protein Kinase C. J. Virol. 76: 11199-11208 [Abstract] [Full Text]  
  • Polson, A. G., Huang, L., Lukac, D. M., Blethrow, J. D., Morgan, D. O., Burlingame, A. L., Ganem, D. (2001). Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Protein Is Phosphorylated by Cyclin-Dependent Kinases. J. Virol. 75: 3175-3184 [Abstract] [Full Text]  
  • Segouffin-Cariou, C., Farjot, G., Sergeant, A., Gruffat, H. (2000). Characterization of the Epstein-Barr virus BRRF1 gene, located between early genes BZLF1 and BRLF1. J. Gen. Virol. 81: 1791-1799 [Abstract] [Full Text]  
  • Liu, S., Pavlova, I. V., Virgin, H. W. IV, Speck, S. H. (2000). Characterization of Gammaherpesvirus 68 Gene 50 Transcription. J. Virol. 74: 2029-2037 [Abstract] [Full Text]  
  • Ragoczy, T., Miller, G. (1999). Role of the Epstein-Barr Virus Rta Protein in Activation of Distinct Classes of Viral Lytic Cycle Genes. J. Virol. 73: 9858-9866 [Abstract] [Full Text]